Literature DB >> 18376313

Interleukin 22 receptor 1 expression in pancreas islets.

Makoto Shioya1, Akira Andoh, Satoe Kakinoki, Atsushi Nishida, Yoshihide Fujiyama.   

Abstract

OBJECTIVES: Interleukin (IL) 22 is a recently identified T-cell-derived cytokine. IL-22 binds at the cell surface to a heterodimer receptor complex composed of IL-22 receptor (R) 1 and IL-10R2. In this study, we performed immunohistochemical analyses for IL-22R1 expression in human pancreatic tissue.
METHODS: Normal human pancreatic tissue (n = 8) was immunostained with antihuman IL-22R1 antibodies following standard immunohistochemical procedures.
RESULTS: In the normal human pancreas, IL-22R1 was expressed in the islets of Langerhans. IL-22R1 was not expressed by the acinar cells and ductal epithelium. Double-immunostaining experiments showed that the majority of insulin-expressing beta cells and glucagon-expressing alpha cells were immunopositive for IL-22R1.
CONCLUSIONS: The islets of Langerhans are the local site for IL-22R1 expression in the human pancreas. It may be that the T-cell-mediated immune response modulates cell islet function through IL-22 signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376313     DOI: 10.1097/MPA.0b013e3181594258

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  18 in total

1.  Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress.

Authors:  Sumaira Z Hasnain; Danielle J Borg; Brooke E Harcourt; Hui Tong; Yonghua H Sheng; Choa Ping Ng; Indrajit Das; Ran Wang; Alice C-H Chen; Thomas Loudovaris; Thomas W Kay; Helen E Thomas; Jonathan P Whitehead; Josephine M Forbes; Johannes B Prins; Michael A McGuckin
Journal:  Nat Med       Date:  2014-11-02       Impact factor: 53.440

2.  Interleukin 22 signaling promotes cell growth in mantle cell lymphoma.

Authors:  Pascal Gelebart; Zoulika Zak; Jennifer Dien-Bard; Mona Anand; Raymond Lai
Journal:  Transl Oncol       Date:  2011-02-01       Impact factor: 4.243

3.  Pro-tumour activity of interleukin-22 in HPAFII human pancreatic cancer cells.

Authors:  L M Curd; S E Favors; R K Gregg
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

4.  Androgen receptor-deficient islet β-cells exhibit alteration in genetic markers of insulin secretion and inflammation. A transcriptome analysis in the male mouse.

Authors:  Weiwei Xu; Tianhua Niu; Beibei Xu; Guadalupe Navarro; Matthew J Schipma; Franck Mauvais-Jarvis
Journal:  J Diabetes Complications       Date:  2017-03-09       Impact factor: 2.852

Review 5.  Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.

Authors:  Christian Fercher; Sahar Keshvari; Michael A McGuckin; Ross T Barnard
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-19

Review 6.  Interleukin-22: immunobiology and pathology.

Authors:  Jarrod A Dudakov; Alan M Hanash; Marcel R M van den Brink
Journal:  Annu Rev Immunol       Date:  2015-02-11       Impact factor: 28.527

Review 7.  Lymphocyte roles in metabolic dysfunction: of men and mice.

Authors:  Blanche C Ip; Andrew E Hogan; Barbara S Nikolajczyk
Journal:  Trends Endocrinol Metab       Date:  2015-01-05       Impact factor: 12.015

Review 8.  Emerging role of testosterone in pancreatic β-cell function and insulin secretion.

Authors:  Weiwei Xu; Jamie Morford; Franck Mauvais-Jarvis
Journal:  J Endocrinol       Date:  2019-01-01       Impact factor: 4.286

Review 9.  IL-22 in tissue-protective therapy.

Authors:  Heiko Mühl; Patrick Scheiermann; Malte Bachmann; Lorena Härdle; Anika Heinrichs; Josef Pfeilschifter
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 10.  Therapeutic opportunities of the IL-22-IL-22R1 system.

Authors:  Robert Sabat; Wenjun Ouyang; Kerstin Wolk
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.